Palladium Partners’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-36,000
| Closed | – | – | 301 |
|
|
2021
Q2 | $0 | Sell |
36,000
-357,900
| -91% | -$1.42M | ﹤0.01% | 292 |
|
|
2021
Q1 | $1.56M | Hold |
393,900
| – | – | 0.08% | 149 |
|
|
2020
Q4 | $918K | Hold |
393,900
| – | – | 0.05% | 168 |
|
|
2020
Q3 | $854K | Buy |
393,900
+20,000
| +5% | +$46.6K | 0.05% | 163 |
|
|
2020
Q2 | $774K | Buy |
373,900
+25,000
| +7% | +$50.5K | 0.05% | 165 |
|
|
2020
Q1 | $468K | Hold |
348,900
| – | – | 0.04% | 179 |
|
|
2019
Q4 | $1.21M | Buy |
348,900
+141,000
| +68% | +$445K | 0.08% | 151 |
|
|
2019
Q3 | $821K | Hold |
207,900
| – | – | 0.06% | 162 |
|
|
2019
Q2 | $630K | Hold |
207,900
| – | – | 0.04% | 186 |
|
|
2019
Q1 | $553K | Hold |
207,900
| – | – | 0.04% | 187 |
|
|
2018
Q4 | $634K | Hold |
207,900
| – | – | 0.05% | 172 |
|
|
2018
Q3 | $821K | Buy |
207,900
+16,000
| +8% | +$59K | 0.06% | 168 |
|
|
2018
Q2 | $595K | Hold |
191,900
| – | – | 0.04% | 186 |
|
|
2018
Q1 | $489K | Hold |
191,900
| – | – | 0.04% | 196 |
|
|
2017
Q4 | $509K | Sell |
191,900
-16,000
| -8% | -$35.7K | 0.04% | 196 |
|
|
2017
Q3 | $541K | Buy |
207,900
+16,000
| +8% | +$49.2K | 0.04% | 187 |
|
|
2017
Q2 | $1.09M | Sell |
191,900
-5,000
| -3% | -$32.5K | 0.09% | 142 |
|
|
2017
Q1 | $1.61M | Sell |
196,900
-25,000
| -11% | -$173K | 0.13% | 119 |
|
|
2016
Q4 | $1.17M | Hold |
221,900
| – | – | 0.1% | 136 |
|
|
2016
Q3 | $845K | Buy |
221,900
+116,000
| +110% | +$444K | 0.07% | 154 |
|
|
2016
Q2 | $414K | Hold |
105,900
| – | – | 0.04% | 187 |
|
|
2016
Q1 | $348K | Hold |
105,900
| – | – | 0.03% | 195 |
|
|
2015
Q4 | $312K | Hold |
105,900
| – | – | 0.03% | 204 |
|
|
2015
Q3 | $339K | Buy |
+105,900
| New | +$383K | 0.03% | 191 |
|
Palladium Partners's CRHM Position: Q3 2021 in Review
Palladium Partners sold out of CRH Medical Corporation (CRHM) in Q3 2021, closing a stake of 36,000 shares.
Palladium Partners first reported a position in CRHM in Q3 2015 and held it in 24 quarters. The position peaked at $1.61M in Q1 2017. 0 funds tracked by Wall St. Rank hold CRHM as of Q3 2021.
- Palladium Partners reported no remaining CRH Medical Corporation position as of Q3 2021 after selling out during the quarter.
- Palladium Partners sold 36,000 CRH Medical Corporation shares in Q3 2021.
- Palladium Partners first reported a position in CRH Medical Corporation in Q3 2015 and held it in 24 quarters.
- Palladium Partners's CRH Medical Corporation position peaked at $1.61M in Q1 2017.
- 0 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q3 2021.
Based on Palladium Partners's 13F filing for Q3 2021, filed 26 Oct 2021.